FTSE 100 headed higher at start of the week thanks to progress on the vaccine front and reports that the November lockdown cut coronavirus infections by a third. London's leading index advanced 4 points to 6,372 in early trading.
The UK is expected to authorise the COVID-19 vaccine candidate developed by Pfizer Inc. (NYSE:PFE) and BioNTech this week. The rollout could start as early as December 7, while the country has secured 40mln doses.
Frasers Group PLC (LON:FRAS), the sports retail group run by Mike Ashley, has offered funding of up to £50mln to struggling retailer Arcadia Group. The Topshop owner is facing administration as early as Monday, risking 13,000 jobs.
Symphony Environmental Technologies PLC (LON:SYM) shares shot after a highly successful coronavirus (COVID-19) test of anti-viral gloves and masks containing the company’s d2pAM antimicrobial technology. The assessment was carried out in Brazil.
CentralNic Group PLC saw revenue more than double year-on-year in the first nine months of 2020, with record organic revenue growth of 17%. The internet platform operator posted revenue up 118%.
Scotgold Resources Ltd (LON:SGZ) is on course to start Phase 1 production at the Cononish gold and silver mine in the Trossachs later today. This phase targets average annual gold equivalent production of 9,910 ounces.